{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T11:48:49Z","timestamp":1794829729042,"version":"4.9.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","award":["GHN-A-00-08-00004"],"award-info":[{"award-number":["GHN-A-00-08-00004"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Stage 1 of the STREAM trial demonstrated that the 9 month (Short) regimen developed in Bangladesh was non-inferior to the 20 month (Long) 2011 World Health Organization recommended regimen. We assess the association between HIV infection and radiographic manifestations of tuberculosis and factors associated with time to culture conversion in Stage 1 of the STREAM trial.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Reading of chest radiographs was undertaken independently by two clinicians, and films with discordant reading were read by a third reader. Recording of abnormal opacity of the lung parenchyma included location (right upper, right lower, left upper, and left lower) and extent of disease (minimal, moderately-advanced, and far advanced). Time to culture conversion was defined as the number of days from initiation of treatment to the first of two consecutive negative culture results, and compared using the log-rank test, stratified by country. Cox proportional hazards models, stratified by country and adjusted for HIV status, were used to identify factors associated with culture conversion.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the 364 participants, all but one had an abnormal chest X-ray: 347 (95%) had opacities over upper lung fields, 318 (87%) had opacities over lower lung fields, 124 (34%) had far advanced pulmonary involvement, and 281 (77%) had cavitation. There was no significant association between HIV and locations of lung parenchymal opacities, extent of opacities, the presence of cavitation, and location of cavitation. Participants infected with HIV were significantly less likely to have the highest positivity grade (3+) of sputum culture (<jats:italic>p<\/jats:italic>\u2009=\u20090.035) as compared to participants not infected with HIV. Cavitation was significantly associated with high smear positivity grades (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and high culture positivity grades (<jats:italic>p<\/jats:italic>\u2009=\u20090.004) among all participants. Co-infection with HIV was associated with a shorter time to culture conversion (hazard ratio 1.59, 95% CI 1.05\u20132.40).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Radiographic manifestations of tuberculosis among the HIV-infected in the era of anti-retroviral therapy may not differ from that among those who were not infected with HIV. Radiographic manifestations were not consistently associated with time to culture conversion, perhaps indicating that the Short regimen is sufficiently powerful in achieving sputum conversion across the spectrum of radiographic pulmonary involvements.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ISRCTN ISRCTN78372190. Registered 14\/10\/2010. The date of first registration 10\/02\/2016.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-024-09039-z","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T10:03:07Z","timestamp":1706608987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Radiographic characteristics of rifampicin-resistant tuberculosis in the STREAM stage 1 trial and their influence on time to culture conversion in the short regimen"],"prefix":"10.1186","volume":"24","author":[{"given":"Chen-Yuan","family":"Chiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Bern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Goodall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-Tien","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. D.","family":"Rusen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Nunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the STREAM Sub-study Collaborators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oumer","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mekonnen","family":"Teferi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muziwandile","family":"Ndlovu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nosipho","family":"Ngubane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Bennet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Fabiane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Meredith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naranbat","family":"Nyamda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bazarragchaa","family":"Tsogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phan-Thuong","family":"Dat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meseret","family":"Hailu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Meressa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Aucock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronelle","family":"Moodliar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,30]]},"reference":[{"key":"9039_CR1","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1164\/rccm.201001-0077OC","volume":"182","author":"A Van Deun","year":"2010","unstructured":"Van Deun A, Aung KJM, Salim MAH, Kumar Das P, Ranjan Sarker M, Daru P, et al. Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis. Am J Respir Crit Care Med. 2010;182:684\u201392.","journal-title":"Am J Respir Crit Care Med"},{"key":"9039_CR2","unstructured":"World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. 2011 update. World Health Organization Document.\u00a0Geneva: WHO\/HTM\/TB\/2011.6; 2011."},{"key":"9039_CR3","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJMoa1811867","volume":"380","author":"AJ Nunn","year":"2019","unstructured":"Nunn AJ, Phillips PPJ, Meredith SK, Chiang CY, Conradie F, Dalai D, et al. A trial of a shorter regimen for rifampin-resistant tuberculosis. N Engl J Med. 2019;380:1201\u201313.","journal-title":"N Engl J Med"},{"key":"9039_CR4","doi-asserted-by":"publisher","first-page":"348","DOI":"10.5588\/ijtld.12.0100","volume":"17","author":"J Hafkin","year":"2013","unstructured":"Hafkin J, Modongo C, Newcomb C, Lowenthal E, MacGregor RR, Steenhoff AP, et al. Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana. Int J Tuberc Lung Dis. 2013;17:348\u201353.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"9","key":"9039_CR5","doi-asserted-by":"publisher","first-page":"e73975","DOI":"10.1371\/journal.pone.0073975","volume":"8","author":"JCM Brust","year":"2013","unstructured":"Brust JCM, Berman AR, Zalta B, Haramati LB, Ning Y, Heo M, et al. Chest radiograph findings and time to culture conversion in patients with multidrug-resistant tuberculosis and HIV in Tugela Ferry, South Africa. PLoS One. 2013;8(9):e73975. https:\/\/doi.org\/10.1371\/journal.pone.0073975","journal-title":"PLoS One"},{"key":"9039_CR6","doi-asserted-by":"publisher","first-page":"650","DOI":"10.7326\/0003-4819-144-9-200605020-00008","volume":"144","author":"TH Holtz","year":"2006","unstructured":"Holtz TH, Sternberg M, Kammerer S, Laserson KF, Riekstina V, Zarovska E, et al. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome. Ann Intern Med. 2006;144:650\u20139.","journal-title":"Ann Intern Med"},{"key":"9039_CR7","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0140-6736(05)17786-1","volume":"365","author":"V Leimane","year":"2005","unstructured":"Leimane V, Riekstina V, Holtz TH, Zarovska E, Skripconoka V, Thorpe LE, et al. Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study. Lancet. 2005;365:318\u201326.","journal-title":"Lancet"},{"key":"9039_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev.med.46.1.47","volume":"46","author":"RE Huebner","year":"1995","unstructured":"Huebner RE, Castro KG. The changing face of tuberculosis. Annu Rev Med. 1995;46:47\u201355.","journal-title":"Annu Rev Med"},{"key":"9039_CR9","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1164\/ajrccm.152.5.7582294","volume":"152","author":"AL Pozniak","year":"1996","unstructured":"Pozniak AL, MacLeod GA, Ndlovu D, Ross E, Mahari M, Weinberg J. Clinical and chest radiographic features of tuberculosis associated with human immunodeficiency virus in Zimbabwe. Am J Respir Crit Care Med. 1996;152:1558\u201361.","journal-title":"Am J Respir Crit Care Med"},{"key":"9039_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S1201-9712(96)90073-9","volume":"1","author":"J Batungwanayo","year":"1996","unstructured":"Batungwanayo J, Taelman H, Bogaerts J, Clerinx J, Kagame A, Van Deun A, et al. Impact of human immunodeficiency virus infection on tuberculosis in Kigali, Rwanda: one-year study of 377 consecutive cases. Int J Infect Dis. 1996;1:22\u20137.","journal-title":"Int J Infect Dis"},{"key":"9039_CR11","first-page":"393","volume":"131","author":"AE Pitchenik","year":"1985","unstructured":"Pitchenik AE, Rubinson HA. The radiographic appearance of tuberculosis in patients with the acquired immune deficiency syndrome (AIDS) and pre-AIDS. Am Rev Respir Dis. 1985;131:393\u20136.","journal-title":"Am Rev Respir Dis"},{"key":"9039_CR12","first-page":"1295","volume":"14","author":"G Chamie","year":"2010","unstructured":"Chamie G, Luetkemeyer A, Walusimbi-Nanteza M, Okwera A, Whalen CC, Mugerwa RD, et al. Significant variation in presentation of pulmonary tuberculosis across a high resolution of CD4 strata. Int J Tuberc Lung Dis. 2010;14:1295\u2013302.","journal-title":"Int J Tuberc Lung Dis"},{"key":"9039_CR13","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1086\/514546","volume":"25","author":"DC Perlman","year":"1997","unstructured":"Perlman DC, El-Sadr WM, Nelson ET, Matts JP, Telzak EE, Salomon N, et al. Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. Clin Infect Dis. 1997;25:242\u20136.","journal-title":"Clin Infect Dis"},{"key":"9039_CR14","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/0962-8479(95)90527-8","volume":"76","author":"FA Post","year":"1995","unstructured":"Post FA, Wood R, Pillay GP. Pulmonary tuberculosis in HIV infection: radiographic appearance is related to CD4+ T-lymphocyte count. Tuber Lung Dis. 1995;76:518\u201321.","journal-title":"Tuber Lung Dis"},{"issue":"4","key":"9039_CR15","doi-asserted-by":"publisher","first-page":"e93397","DOI":"10.1371\/journal.pone.0093397","volume":"9","author":"CY Chiang","year":"2014","unstructured":"Chiang CY, Lee JJ, Chien ST, Enarson DA, Chang YC, Chen YT, et al. Glycemic control and radiographic manifestations of tuberculosis in diabetic patients. PLoS One. 2014;9(4):e93397. https:\/\/doi.org\/10.1371\/journal.pone.0093397.","journal-title":"PLoS One"},{"key":"9039_CR16","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1164\/rccm.200905-0692OC","volume":"180","author":"P Mongkongdee","year":"2009","unstructured":"Mongkongdee P, McCarthy KD, Cain KP, Tasaneeyapan T, Dung NH, Lan NTN, et al. Yield of acid-fast smear and mycobacterial culture for tuberculosis diagnosis in people with human immunodficiency virus. Am J Respir Crit Care Med. 2009;180:903\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"9039_CR17","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1016\/S1473-3099(18)30537-1","volume":"19","author":"PY Khan","year":"2019","unstructured":"Khan PY, Yates TA, Osman M, Warren RM, van der Heijden Y, Padayatchi N, et al. Transmission of drug-resistant tuberculosis in HIV-endemic settings. [Tuberculosis transmission in HIV-endemic settings 2]. Lancet Infect Dis. 2019;19:e77\u201388.","journal-title":"Lancet Infect Dis"},{"key":"9039_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12916-018-1053-3","volume":"16","author":"SE Murthy","year":"2018","unstructured":"Murthy SE, Chatterjee F, Crook A, Dawson R, Mendel C, Murphy ME, et al. Pretreatment chest X-ray severity and its relation to bacterial burden in smear positive pulmonary tuberculosis. BMC Med. 2018;16:73.","journal-title":"BMC Med"},{"issue":"5512","key":"9039_CR19","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1136\/bmj.2.5512.491","volume":"2","author":"G Simon","year":"1966","unstructured":"Simon G. Radiology in epidemiological studies and some therapeutic trials. Br Med J. 1966;2(5512):491\u20134.","journal-title":"Br Med J"},{"key":"9039_CR20","first-page":"68","volume-title":"Diagnostic standards and classification of tuberculosis","author":"A Falk","year":"1969","unstructured":"Falk A, O\u2019Connor J, Pratt P, et al. Classification of pulmonary tuberculosis. In: Falk A, O\u2019Connor JB, Pratt PC, et al., editors. Diagnostic standards and classification of tuberculosis, vol. 12. New York: National Tuberculosis and Respiratory Disease Association; 1969. p. 68\u201376."},{"key":"9039_CR21","first-page":"1088","volume":"9","author":"S Den Boon","year":"2005","unstructured":"Den Boon S, Bateman ED, Enarson DA, Borgdorff MW, Verver S, Lombard CJ, et al. Development and evaluation of a new chest radiograph reading and recording system for epidemiological surveys of tuberculosis and lung disease. Int J Tuberc Lung Dis. 2005;9:1088\u201396.","journal-title":"Int J Tuberc Lung Dis"},{"key":"9039_CR22","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1136\/thx.2010.136242","volume":"65","author":"AP Ralph","year":"2010","unstructured":"Ralph AP, Ardian M, Wiguna A, Maguire GP, Becker NG, Drogmuller G, et al. A simple, valid, numerical score for grading chest x-ray severity in adult smear-positive pulmonary tuberculosis. Thorax. 2010;65:863\u20139.","journal-title":"Thorax"},{"key":"9039_CR23","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1183\/09031936.00107412","volume":"42","author":"LM Pinto","year":"2013","unstructured":"Pinto LM, Pai M, Dheda K, Schwartzman K, Menzies D, Steingart KR. Scoring systems using chest radiographic features for the diagnosis of pulmonary tuberculosis in adults: a systematic review. Eur Respir J. 2013;42:480\u201394.","journal-title":"Eur Respir J"},{"key":"9039_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ijid.2018.10.026","volume":"79","author":"JB te Riele","year":"2019","unstructured":"te Riele JB, Buser V, Calligaro G, Esmail A, Theron G, Lesosky M, et al. Relationship between chest radiographic characteristics, sputum bacterial load, and treatment outcomes in patients with extensively drug-resistant tuberculosis. Intern J Infect Dis. 2019;79:65\u201371.","journal-title":"Intern J Infect Dis"},{"issue":"12","key":"9039_CR25","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1128\/JCM.01780-07","volume":"45","author":"M Palaci","year":"2007","unstructured":"Palaci M, Dietze R, Hadad DJ, Ribeiro FK, Peres RL, Vinhas SA, et al. Cavitary disease and quantitative sputum bacillary load in cases of pulmonary tuberculosis. J Clin Microbiol. 2007;45(12):4064\u20136.","journal-title":"J Clin Microbiol"},{"key":"9039_CR26","first-page":"1596","volume":"14","author":"FMR Perrin","year":"2010","unstructured":"Perrin FMR, Woodward N, Phillips PPJ, McHugh TD, Nunn AJ, Lipman MCI, et al. Radiological cavitation, sputum mycobacterial load and treatment response in pulmonary tuberculosis. Int J Tuberc Lung Dis. 2010;14:1596\u2013602.","journal-title":"Int J Tuberc Lung Dis"},{"key":"9039_CR27","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1086\/513772","volume":"25","author":"EE Telzak","year":"1997","unstructured":"Telzak EE, Fazal BA, Pollard CL, Turett GS, Justman JE, Blum S. Factors influencing time to sputum conversion among patients with smear-positive pulmonary tuberculosis. Clin Infect Dis. 1997;25:666\u201370.","journal-title":"Clin Infect Dis"},{"key":"9039_CR28","doi-asserted-by":"publisher","first-page":"1602363","DOI":"10.1183\/13993003.02363-2016","volume":"49","author":"C Magis-Escurra","year":"2017","unstructured":"Magis-Escurra C, G\u00fcnther G, Lange C, Alexandru S, Altet N, Avsar K, et al. Treatment outcomes of MDR-TB and HIV co-infection in Europe. (Research letter). Eur Respir J. 2017;49:1602363.","journal-title":"Eur Respir J"},{"key":"9039_CR29","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1164\/rccm.200901-0078OC","volume":"180","author":"SE Dorman","year":"2009","unstructured":"Dorman SE, Johnson JL, Goldberg S, Muzanye G, Padayatchi N, Bozeman L, et al. Substitution of moxifloxacin for isoniazid during intensive phase treatment or pulmonary tuberculosis. Am J Respir Crit Care Med. 2009;180:273\u201380.","journal-title":"Am J Respir Crit Care Med"},{"key":"9039_CR30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1164\/rccm.200603-360OC","volume":"174","author":"WJ Burman","year":"2006","unstructured":"Burman WJ, Goldberg S, Johnson JL, Muzanye G, Engle M, Mosher AW, et al. Moxifloxacin versus ethambutol in the first two months of treatment for pulmonary tuberculosis. Am J Respir Crit Care Med. 2006;174:331\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"9039_CR31","doi-asserted-by":"publisher","first-page":"e1001932","DOI":"10.1371\/journal.pmed.1001932","volume":"12","author":"CM Yuen","year":"2015","unstructured":"Yuen CM, Kurbatova EV, Tupasi T, Campos Caoili J, Van Der Walt M, Kvasnovsky C, et al. Association between regimen composition and treatment response in patients with multidrug-resistant tuberculosis: a prospective cohort study. PLoS Med. 2015;12:e1001932.","journal-title":"PLoS Med"},{"issue":"6","key":"9039_CR32","doi-asserted-by":"publisher","first-page":"e0199320","DOI":"10.1371\/journal.pone.0199320","volume":"13","author":"T Yihunie Akalu","year":"2018","unstructured":"Yihunie Akalu T, Muchie KF, Alemu Gelaye K. Time to sputum culture conversion and its determinants among multi-drug resistant tuberculosis patients at public hospitals of the Amhara Regional State: a multicenter retrospective follow up study. PLoS One. 2018;13(6):e0199320.","journal-title":"PLoS One"},{"key":"9039_CR33","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12916-015-0320-9","volume":"13","author":"AD Kerkhoff","year":"2015","unstructured":"Kerkhoff AD, Wood R, Cobelens FG, Gupta-Wright A, Bekker LG, Lawn SD. The predictive value of current haemoglobin levels for incident tuberculosis and\/or mortality during long-term antiretroviral therapy in South Africa: a cohort study. BMC Med. 2015;13:70.","journal-title":"BMC Med"},{"issue":"3","key":"9039_CR34","doi-asserted-by":"publisher","first-page":"e91229","DOI":"10.1371\/journal.pone.0091229","volume":"9","author":"TJ Nagu","year":"2014","unstructured":"Nagu TJ, Spiegelman D, Hertzmark E, Aboud S, Makani J, Matee MI, et al. Anemia at the initiation of tuberculosis therapy is associated with delayed sputum conversion among pulmonary tuberculosis patients in Dar-es-Salaam, Tanzania. PLoS One. 2014;9(3):e91229. https:\/\/doi.org\/10.1371\/journal.pone.0091229.","journal-title":"PLoS One"},{"key":"9039_CR35","doi-asserted-by":"crossref","first-page":"e0245458","DOI":"10.1371\/journal.pone.0245458","volume":"16","author":"E Beyker de Mendon\u00e7a","year":"2021","unstructured":"Beyker de Mendon\u00e7a E, ArnanStanis Schmaltz C, Sant\u2019Anna M, Gomes Vizzoni A, Palheiro Mendes-de-Almeida D, de Vasconcellos Carvalhaes de Oliveira R, et al. Anemia in tuberculosis cases: a biomarker of disease severity? [Erratum appears in PLoS One 2021;16:e0249545]. PLoS One. 2021;16:e0245458.","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"9039_CR36","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1016\/S1472-9792(08)70038-6","volume":"88","author":"PR Donald","year":"2008","unstructured":"Donald PR, Diacon AH. The early bactericidal activity of anti-tuberculosis drugs: a literature review. Tuberculosis. 2008;88(Suppl 1):S75\u201383.","journal-title":"Tuberculosis"},{"key":"9039_CR37","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa1407426","volume":"371","author":"SH Gillespie","year":"2014","unstructured":"Gillespie SH, Crook AM, McHugh TD, Mendel CM, Meredith SK, Murray SR, et al. Four-monthmoxifloxacin-based regimens for drug-sensitive tuberculosis. N Engl J Med. 2014;371:1577\u201387.","journal-title":"N Engl J Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09039-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09039-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09039-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T10:03:51Z","timestamp":1706609031000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09039-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,30]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9039"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09039-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,30]]},"assertion":[{"value":"14 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Union\u2019s Ethics Advisory Group, Armauer Hansen Research Institute (AHRI) \/ALERT Center Ethics Review Committee, Ethiopian Ministry of Health; Federal Democratic Republic of Ethiopia Ministry of Science and Technology, National Research Ethics Review Committee; Research Ethical Review Committee, St. Peter\u2019s Specialized Hospital; University of Witwatersrand Human Research Ethics Committee; University of KwaZulu-Natal Biomedical Research Ethics Committee; Ethics Medical Monitoring Committee at the Ministry of Health and Sports, Mongolia; and Pham Ngoc Thach Hospital Institute Review Board approved the study. Informed consent has been obtained from all participants. All the procedures were followed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"144"}}